2Poirel L, Menuteau O, Agoli N, et al.Outbreak of extended-spectrum betalactamase VEB-l-producing isolates of Acinetobacter baumannii in a French hospital[ J]. J Clin Microbiol,2003,41(8) :3542 -3547.
7Perez F,Nancy H. Detection of plasmidmediate AmpC β-lactamase genes in clinical isolates by using multiplex PCR[J]. Journal of Clinical Microbiology,2002,40:2153 - 2162.
10Ruiz J,Navia MM,Casals C,et al. Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain[J]. Clin Microbiol Infect,2003,9(9) :907 -911.
二级参考文献55
1Jean SS, Teng LJ, Hsueh PR, et al. Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Cram-negative bacteria in a Taiwan Residents university hospital[ J ]. J Antimicro Chemother ,2002,49 : 69 - 76.
2Héritier C, Poirel L, Aubert D, et al. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii [J]. Antimicro Agents Chemother, 2003, 47:268 -273.
3Lopeg-Otsoa F, Gallego L, Towner K J , et al. Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern spain[J]. J Clin Microbiol, 2002, 40:4741-4743.
4Mfal Shah M, Woodford N, Livermore DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of acinetobacter baumannii [ J ]. Antimicro Agents Chemother,2001.45:583 - 588.
5Vila J, M. Navia, J Ruiz, et al. Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived-lactamase in Acinetobacter baumannii[J]. Antimicro Agents Chemother.1997,41:2757-2759.
6Chu YW,Afzal - Shah M, Houang E T S, et al. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp.Collected in Hong Kong between 1994 and 1998[J]. Antimicro Agents Chemother, 2001,45:710-714.
7Vahaboglu, H Ozturk, R Aygun, G et al. Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study[J]. Antimicro Agents Chemother, 1997, 41:2265 -2269.
8Nuesch-Inderbinen MT, Kayser FH, Hachler H. Survey and molecular genetics of SHV beta - lactamases in Enterobacteriaceae in Switzerland : two novel enzymes [ J ]. SHV-11 and SHV-12 Antimicro Agents Chemother, 1997, 41:943-949.
10Bradford PA. Extended-spectrum-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat[J]. Clin Microbiol Rev, 2001, 14:933 - 951.
2Kim MH,Cha KS, Kim HJ,et al. Primary stenting for acute myocardial infarction via the trans-radial approach safe and useful alternative to the transradial approach[J]. J Invasive Cardiol, 2000,12(6) .. 292-296.
3Hejnar P,Kolar M, Hajek V. Characteristics of Acinetobacter strains (Phenotype classification,antibiotic susceptibility and production of beta-lactamases) isolated from haemocultures from patients at the Teaching Hospital in Olomouc[J]. Acta Univ Palacki Olomous Fac Med, 1999, 142(1) :73-77.
4Magnet S,Courvalin P, Lambert T. Resistance-nodulationcell division type efflux pump involved in aminoglycoside resistance in acinetobacter baumannii strain BM 445[J]. Antimicrob Agent Chemother,2001,45 : 3375-3380.
5Vial J,Ruiz J,Goni P, et al. Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acineto bacter baumanniiJ[J]. Antimicro Agents Chemother, 1995,39 (5) : 1201-1203.
6Vahaboglu H, Coskunkan F, Tansel O, et al. Clinical importance of extended-spectrum β-laetamase(PER-1-type)- producing Acinetobacter spp. and Pseudomonas aeruginosa strains[J]. Med Microbiol, 2001,50 : 642-645.
7Joshi SG, Litake GM, Ghole VS, et al. Plasmid borne extended spectrum β lactamase in a clinical isolate of Acinetobacter baumannii [J]. Med Microbiol, 2003, 52: 1125- 1127.
8Rice LB. Emerging issues in the management of infections caused by multidrug-resistant gram-negative bacteria[J]. Cleve Clin Med, 2007,74 (Suppl 4) : S12-S20.
9Rossolini GM, Mantengoli E. Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains[J]. New Microbiol, 2007,30(3) : 332- 339.
10Tiengrim S,Tribuddharat C, Thamlikitkul V. In vitro activity of tigecycline against clinical isolates of muhidrugresistant Acinetobacter baumannii in Siriraj Hospital, Thailand[J]. Med Assoc Thai, 2006,89 ( Suppl 5) : S102- S105.
